{
    "clinical_study": {
        "@rank": "19920", 
        "arm_group": {
            "arm_group_label": "FMT by endoscopy", 
            "arm_group_type": "Experimental", 
            "description": "Once, fresh or frozen bacteria"
        }, 
        "brief_summary": {
            "textblock": "The gut microbiota is considered to constitute a \"microbial organ\" which has pivotal roles\n      in the body's metabolism. Evidence from animal and human studies strongly support the link\n      between intestinal bacteria and type 2 diabetes mellitus. The present clinical trial aims to\n      re-establish a gut functionality state of intestinal flora through fecal microbiota\n      transplantation."
        }, 
        "brief_title": "Fecal Microbiota Transplantation on Type 2 Diabetes Mellitus", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Efficiency", 
            "Methodology"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "detailed_description": {
            "textblock": "We established a standard bacteria isolation from donated fresh stool in lab.Then the\n      bacteria is transplanted to mid-gut (at least below the second part of duodenum ) through\n      regular gastroscope. Participants in this study will be randomly assigned to receive fecal\n      microbiota transplantation only once or traditional therapy, and accept follow-up for at\n      least one year. Blood tests,OGTT and magnetic resonance spectroscopy will be used to assess\n      participants at study start and at study completion."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Type 2 diabetes mellitus\n\n        Exclusion Criteria:\n\n        With any cause of liver disease other than fatty liver Known or suspected cirrhosis\n        Inability or unwillingness to undergo OGTT and magnetic resonance procedures Requirement\n        of long-term antibiotic therapy Pregnancy, breast-feeding, or plans to become pregnant"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01790711", 
            "org_study_id": "FMT-CN-121025"
        }, 
        "intervention": {
            "arm_group_label": "FMT by endoscopy", 
            "intervention_name": "FMT through mid-gut", 
            "intervention_type": "Procedure", 
            "other_name": "FMT through mid-gut by gastroscope"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Gut bacteria", 
            "Bacteria", 
            "Fecal transplant", 
            "Bacteriotherapy"
        ], 
        "lastchanged_date": "December 15, 2013", 
        "link": {
            "description": "Fecal microbiota transplantation", 
            "url": "http://www.ncbi.nlm.nih.gov/pubmed"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Nanjing", 
                    "country": "China", 
                    "state": "Jiangsu", 
                    "zip": "210011"
                }, 
                "name": "Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "1", 
        "official_title": "The Efficiency of Fecal Microbiota Transplantation on Type 2 Diabetes Mellitus", 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "China: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Confirmed by the tests of blood glucose level, OGTT, HACb1 and C-peptide.", 
            "measure": "The Efficiency of FMT on T2DM", 
            "safety_issue": "No", 
            "time_frame": "Up to 24 months"
        }, 
        "reference": [
            {
                "PMID": "22728514", 
                "citation": "Vrieze A, Van Nood E, Holleman F, Saloj\u00e4rvi J, Kootte RS, Bartelsman JF, Dallinga-Thie GM, Ackermans MT, Serlie MJ, Oozeer R, Derrien M, Druesne A, Van Hylckama Vlieg JE, Bloks VW, Groen AK, Heilig HG, Zoetendal EG, Stroes ES, de Vos WM, Hoekstra JB, Nieuwdorp M. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012 Oct;143(4):913-6.e7. doi: 10.1053/j.gastro.2012.06.031. Epub 2012 Jun 20. Erratum in: Gastroenterology. 2013 Jan;144(1):250."
            }, 
            {
                "PMID": "22863002", 
                "citation": "Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, B\u00e4ckhed HK, Gonzalez A, Werner JJ, Angenent LT, Knight R, B\u00e4ckhed F, Isolauri E, Salminen S, Ley RE. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 2012 Aug 3;150(3):470-80. doi: 10.1016/j.cell.2012.07.008."
            }, 
            {
                "PMID": "22183182", 
                "citation": "Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol. 2011 Dec 20;9(2):88-96. doi: 10.1038/nrgastro.2011.244. Review."
            }, 
            {
                "PMID": "23041678", 
                "citation": "Aroniadis OC, Brandt LJ. Fecal microbiota transplantation: past, present and future. Curr Opin Gastroenterol. 2013 Jan;29(1):79-84. doi: 10.1097/MOG.0b013e32835a4b3e."
            }, 
            {
                "PMID": "23160295", 
                "citation": "Zhang F, Luo W, Shi Y, Fan Z, Ji G. Should we standardize the 1,700-year-old fecal microbiota transplantation? Am J Gastroenterol. 2012 Nov;107(11):1755; author reply p.1755-6. doi: 10.1038/ajg.2012.251."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01790711"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The Second Hospital of Nanjing Medical University", 
            "investigator_full_name": "Faming Zhang", 
            "investigator_title": "Vice chief, medical center for digestive diseases", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Measure the durability of the therapy effects.Based on the tests of blood glucose level, HACb1 and C-peptide. BMI also will be observed.", 
            "measure": "Durability", 
            "safety_issue": "No", 
            "time_frame": "Up to 12 months"
        }, 
        "source": "The Second Hospital of Nanjing Medical University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The Second Hospital of Nanjing Medical University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}